Key Points
- Lingyan Shi of UC San Diego received the 2025 Emerging Leader in Molecular Spectroscopy Award for her pioneering work in biomedical imaging using vibrational techniques like SRS, while Somaiyeh Dadashi and Maddie Harper were honored with the 2025 Coblentz Student Awards for their work in vibrational spectroscopy.
- Major pharmaceutical companies are relocating manufacturing back to the U.S., creating new opportunities for chemists skilled in GMP, regulatory compliance, and data analysis.
- A new study shows that portable MIR spectrometers, when paired with smart calibration transfer methods, can match lab-based soil analysis accuracy.
This week, Spectroscopy published articles highlighting recent studies in several application areas, including pharmaceuticals, biomedical imaging, and soil analysis. Key techniques highlighted in these articles include stimulated Raman scattering (SRS) and mid-infrared (MIR) spectroscopy. Happy reading!
The 2025 Emerging Leader in Molecular Spectroscopy: Lingyan Shi of the University of California, San Diego
Lingyan Shi, associate professor at the University of California, San Diego, is the 2025 recipient of the Emerging Leader in Molecular Spectroscopy Award. Known for her work in vibrational imaging, Shi’s work has developed advanced biomedical imaging platforms integrating techniques like stimulated Raman scattering (SRS), fluorescence lifetime imaging, and second harmonic generation (1). Her innovations include identifying the “Golden Window” for deep-tissue imaging and creating tools like A-PoD and PRM-SRS for high-resolution, chemically specific imaging (1). Her research spans disease-related metabolism, aging, and neurodegeneration, with publications in top-tier journals and over 3,800 citations (1). Recognized globally with multiple awards, Shi combines optical engineering and molecular biology to drive breakthroughs in metabolic imaging, setting new standards in super-resolution vibrational microscopy.
Big Pharma's Manufacturing Shift Could Provide New Opportunities for Chemists
Pharmaceutical companies like Eli Lilly, Novartis, and AstraZeneca are increasing investments in U.S.-based manufacturing. This trend is happening because of concerns over tariffs and supply chain vulnerabilities are driving a shift away from overseas production (2). For analytical chemists, this signals expanded domestic job opportunities not just in research, but also in manufacturing, quality control, and regulatory compliance. Success in this evolving industry requires knowledge of Good Manufacturing Practices (GMP), supply chain logistics, and regulatory standards (2). Hands-on experience, certifications, and cross-functional skills such as data analysis and process improvement are increasingly becoming valuable. Staying informed through professional networks and industry events will help chemists adapt and thrive in this transforming pharmaceutical landscape.